UA106992U - Способ лечения больных часто рецидивирующим опоясывающим герпесом на фоне вич-инфекции/спида - Google Patents
Способ лечения больных часто рецидивирующим опоясывающим герпесом на фоне вич-инфекции/спида Download PDFInfo
- Publication number
- UA106992U UA106992U UAU201512761U UAU201512761U UA106992U UA 106992 U UA106992 U UA 106992U UA U201512761 U UAU201512761 U UA U201512761U UA U201512761 U UAU201512761 U UA U201512761U UA 106992 U UA106992 U UA 106992U
- Authority
- UA
- Ukraine
- Prior art keywords
- hiv
- herpes zoster
- aids
- treatment
- therapy
- Prior art date
Links
- 208000007514 Herpes zoster Diseases 0.000 title claims abstract description 14
- 230000000306 recurrent effect Effects 0.000 title claims abstract description 8
- 238000000034 method Methods 0.000 title claims abstract description 6
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 12
- 229940079593 drug Drugs 0.000 claims abstract description 11
- 208000030507 AIDS Diseases 0.000 claims abstract description 8
- 230000003602 anti-herpes Effects 0.000 claims abstract description 7
- 230000000686 immunotropic effect Effects 0.000 claims abstract description 6
- 230000001502 supplementing effect Effects 0.000 claims abstract description 4
- 230000000798 anti-retroviral effect Effects 0.000 claims abstract description 3
- 239000007924 injection Substances 0.000 claims abstract 2
- 238000002347 injection Methods 0.000 claims abstract 2
- 208000031886 HIV Infections Diseases 0.000 claims description 12
- 208000037357 HIV infectious disease Diseases 0.000 claims description 12
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims description 12
- 208000015181 infectious disease Diseases 0.000 description 5
- HDOVUKNUBWVHOX-QMMMGPOBSA-N Valacyclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCOC(=O)[C@@H](N)C(C)C)C=N2 HDOVUKNUBWVHOX-QMMMGPOBSA-N 0.000 description 4
- 229960004150 aciclovir Drugs 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229940093257 valacyclovir Drugs 0.000 description 4
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 208000029433 Herpesviridae infectious disease Diseases 0.000 description 2
- 206010061598 Immunodeficiency Diseases 0.000 description 2
- 208000029462 Immunodeficiency disease Diseases 0.000 description 2
- 206010037898 Rash vesicular Diseases 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000007813 immunodeficiency Effects 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 210000003901 trigeminal nerve Anatomy 0.000 description 2
- 241001529453 unidentified herpesvirus Species 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 208000001388 Opportunistic Infections Diseases 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000011225 antiretroviral therapy Methods 0.000 description 1
- 229940124522 antiretrovirals Drugs 0.000 description 1
- 239000003903 antiretrovirus agent Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000007248 cellular mechanism Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- QTCANKDTWWSCMR-UHFFFAOYSA-N costic aldehyde Natural products C1CCC(=C)C2CC(C(=C)C=O)CCC21C QTCANKDTWWSCMR-UHFFFAOYSA-N 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 229960004396 famciclovir Drugs 0.000 description 1
- GGXKWVWZWMLJEH-UHFFFAOYSA-N famcyclovir Chemical compound N1=C(N)N=C2N(CCC(COC(=O)C)COC(C)=O)C=NC2=C1 GGXKWVWZWMLJEH-UHFFFAOYSA-N 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000000544 hyperemic effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- ISTFUJWTQAMRGA-UHFFFAOYSA-N iso-beta-costal Natural products C1C(C(=C)C=O)CCC2(C)CCCC(C)=C21 ISTFUJWTQAMRGA-UHFFFAOYSA-N 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000004719 natural immunity Effects 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 238000002559 palpation Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Способ лечения больных часто рецидивирующим опоясывающим герпесом на фоне ВИЧ-инфекции/СПИДа путем дополнения стандартной противовирусной и противогерпетической терапии. Включает дополнительное применение 3 инъекций иммунотропного препаратов Алокин-альфа в дозе 1 мг подкожно через день.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201512761U UA106992U (ru) | 2015-12-23 | 2015-12-23 | Способ лечения больных часто рецидивирующим опоясывающим герпесом на фоне вич-инфекции/спида |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201512761U UA106992U (ru) | 2015-12-23 | 2015-12-23 | Способ лечения больных часто рецидивирующим опоясывающим герпесом на фоне вич-инфекции/спида |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA106992U true UA106992U (ru) | 2016-05-10 |
Family
ID=57142637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201512761U UA106992U (ru) | 2015-12-23 | 2015-12-23 | Способ лечения больных часто рецидивирующим опоясывающим герпесом на фоне вич-инфекции/спида |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA106992U (ru) |
-
2015
- 2015-12-23 UA UAU201512761U patent/UA106992U/ru unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gross et al. | Effect of dialysate temperature and flow rate on peritoneal clearance | |
| UA106992U (ru) | Способ лечения больных часто рецидивирующим опоясывающим герпесом на фоне вич-инфекции/спида | |
| CREATURO | Infectious mononucleosis and polyneuritis (Guillain-Barré syndrome): report of a case of facial diplegia treated with 2, 3 dimercaptopropanol (BAL) | |
| MARTIN et al. | Disseminated actinomycosis treated with tetracycline | |
| RU2415662C1 (ru) | Способ лечения больных синдромом хронической усталости | |
| RU2538083C1 (ru) | Способ лечения поражения вегетативных парасимпатических узлов головы герпесвирусной этиологии | |
| Dubois | High dosage steroid therapy for systemic lupus erythematosus | |
| NO322176B1 (no) | Anvendelse av pox inducere omfattende en kombinasjon av henholdsvis flere pox virus og parapox virus for fremstilling av medikamentet for prefinal tumorterapi for a lindre smerte og optimalisere velbefinnende til pasienter. | |
| UA120398U (uk) | Спосіб лікування рецидивного віл-асоційованого генітального герпесу | |
| McLoughlin et al. | Post-herpetic abdominal wall herniation. | |
| Khanna et al. | Adipose-derived cell therapy for hand dysfunction in patients with systemic sclerosis: a randomized, double-blind, placebo-controlled trial | |
| RU2555474C1 (ru) | Способ лечения эпштейна-барр вирусной инфекции у детей с вич-инфекцией | |
| RU2816988C1 (ru) | Способ профилактики сезонных рецидивов многоформной экссудативной эритемы | |
| RU2271828C2 (ru) | Способ лечения бронхиальной астмы у детей, часто и/или длительно болеющих орви | |
| Mozhdehipanah et al. | Guillain-Barré Syndrome After Receiving the First Dose of Oxford–AstraZeneca SARS-CoV-2 Vaccine | |
| RU2542421C1 (ru) | Способ лечения атопического дерматита у детей с синдромом вторичной иммунной недостаточности | |
| RU2423143C2 (ru) | Способ лечения больного хроническим бруцеллезом | |
| Win et al. | STEVENS‐JOHNSON SYNDROME PRESUMABLY INDUCED BY CIPROFLOXACIN | |
| KUTLU et al. | Herpes Zoster Reacting with Short-Term Corticosteroid Therapy in a Healthy 8-Year-Old Girl | |
| Broadbent | A surprising presentation of blistering mouth ulcers | |
| Friedlaender et al. | Effect of cortisone administered orally in bronchial asthma | |
| Olisova et al. | The choice of rational treatment regiments for different clinical variants of herpes infection | |
| Slater | Combined Aspirin and Cortisone Treatment of Acute Rheumatic Fever: A Controlled Trial in Young Men | |
| RU2602953C1 (ru) | Способ лечения генерализованной цитомегаловирусной инфекции у детей раннего возраста | |
| O'Neill et al. | HIV seropositivity in a geriatric medical unit. |